Chlorpropamide-alcohol flushing (CPAF) has been reported to be associated with a low prevalence of large and small vessel disease in non insulindependent diabetics' ~',-~' . However, the specificity of the flushing test has recently been questioned ' 7,2~, and the occurrence of the CPAF phenomenon varies considerably in different diabetic clinics -~, ~, ':, ~' ,2°.:2
CHLORPROPAMIDE-ALCOHOL FLUSHING 1N DIABETES ministration and 20 min later, using two small sensor probes fixed by adhesive tape over the forehead and the lateral canthus of the eye, and a digital thermometer for registration. The test was positive if facial flush appeared and there was a sensation of warmth of the face and neck. The mean tem. perature increases in positive patients were 1.4 °C = 0.85 (SD) and 0.4 °C _+ 0.15 (SD) in negative patients. The room temperature was constant at 17 °C (experiments were performed in a fully conditioned area), and the patients were kept waiting 1 h before drinking the sherry.
All the positive patients repeated the alcohol test three months later, with placebo given instead of chlorpropamide.
Clinicatfindings -The eyes of the 108 patients were examined independently through dilated pupils by two expert ophthalmologists unaware of their status as flushers. Patients with no retinal lesions or with fewer than 5 exudates or hemorrhages are pooled together in the nil/minimal group; patients with proliferative retinopathy are not considered separately, as there are too few of them-'-'. Patients with severe retinopathy (more than 5 lesions in at least one eye) are subdivided on the basis of presence or absence of important visual loss (more than 50%1 objectively measured) due to diabetic maculopathy.
Standard electrocardiography was pertormed: the presence of more than 3 extrasystoles over a 2-rain registration, the presence of atrial fibrillation, the presence of left or right bundle branch block, the presence of an atrioventricular conduction time equal or greater than 0.21 sec, were considered pathological findings and pooled together in the 'rhythm or conduction defects'; patients with classical findings of previous myocaidial infarction ' or showing a J-point depression of the S-T segment greater than 1.0 mm or a Jpoint elevation greater than 1 mm were considered ischemic; the lowering or flattening of the T wave with normal S-T segment were not considered as myocardial ischemia whereas the T-wave inversion even if not accompanied by S-T segment alterations was considered a sign of ischemia.
Oscillography was also performed in our subjects at both calves. The findings were classified as abnormal according to the following criteria. A maximal wave amplitude smaller than 5 mm, a maximal wave amplitude reduction in one leg compared to the other of more than 50% were considered to be reduced pulses, whereas the absence of wave was classified as abolished pulse.
Blood pressure was measured at the time of the first alcohol challenge, after 3 min in the supine position: systolic blood pressure was taken at the first Korotko[Fs sound and diastolic blood pressure at the fourth Korotkoffs sound.
Blood sampling . One week after the first alcohol test, the patients came back to the clinic after an overnight fast; a blood sample was drawn through a t9 gauge needle for lipid and hemostasis assays. Hemostatic variables -Factor VIII coagulant activity (VIII:C) was assayed in citrated plasma by a two-stage method ~ and factor VIII-related antigen (VIII R:Ag) by quantitative immunoelectrophoresis ' using a monospecific antiserum to human Factor VIII/yon Willebrandt Factor from rabbit (Istituto Behring, Scoppito/L'Aquila, Italy). The results were expressed as percentage of plasma pooled from 30 normal subjects, snapped frozen and stored at -70 °C.
Plasma fibrinogen was determined by the method of VERMYLEN et al. -' 6 and values are expressed in g/dl. For plasma ~.thromboglobulin (~-TG) measurement 2.7 ml of venous blood were immediately transferred into plastic tubes placed on crushed ice and mixed with 0.3 ml of an antiplatetet anticoagulant freshly prepared by adding 10 l.xg of prostagtandin E~ and 50 mg of theophylline to 10 ml of 10% EDTA< ~-TG was measured in platelet-poor plasma by radioimmunoassay using a commercial kit (Radiochemical Center, Amersham, U.K.), and the values expressed as ng/ml.
Glycosylated hemoglobin (HbA1) was measured using a commercial kit (Fast Hemoglobin Test System, Isolab Inc., Akron/O. U.S.A.) which pools together fractions HbA1 (a+b+c).
Statistical analysis was done by the x<test and the standard Student's ttest for unpaired data. Table t The mean duration of diabetes did not significantly differ among groups, even though it was slightly shorter for the 'true' flushers and slightly longer for the AF than for the CPAF.negative patients. Table 1 also shows that the occurrence of 'true' flushing was similar in the diabetics treated by diet alone and in those treated with oral agents. By contrast, almost all of the aspecific flushers had been on long-term treatment with oral agents. Table 2 shows the prevalence of vascular lesions. Even though CPAFnegative and AF showed a slightly higher prevalence of severe lesions with visual loss there was no significant difference between the groups. Unlike CPAF-negative and AF, none of the CPAF-positive patients showed loss of visual acuity due to maculopathy in spite of the fact that 16% of them had more than five retinal lesions. Table 3 lists the values for other parameters studied in relation to the CPAF test. We did not observe any significant differences among the patient groups in systolic and diastolic blood pressure, total and HDL-cholesterol, triglycerides, VIII:C, VIIIR:Ag, plasma ~-TG or fibrinogen.
RESULTS
As far as metabolic control is concerned, the 'true' flushers showed a mean value of HbA1 of 9.06 ± 0.67% SEM, the CPAF-negative subjects of 9.09 __+ 0.38% SEM, the AF of 9.8 ± 1.08% SEM, The differences among groups are not significant. Table 4 showed the prevalence of lesions when considering women separately. In the CPAF-positive group the prevalence of women with nil/minimal retinal damage is very close to that observed in tab. 2 for the pooled data (86% vs 84%), and the same thing happens for normal electrocardiograms (73% vs 73%) and oscillograms (74% v5 73%). culopathy. In addition, the prevalences of abnormal electrocardiograms and oscillograms are signifcantly higher in non-flushers. These differences in the prevalence of severe lesions cannot be accounted for by obvious differences in the composition of the patient groups, because the mean age and duration of diabetes were not significantly different between 'true' flushers and non-flushers. The aspecific flushers had had slightly longer mean duration of illness, which may explain their higher prevalence of lesions. Apparently this group is not protected against complications, as compared to non.flushers. This study of a large number of patients has also allowed us to evaluate the incidence in our population of a number of variables which might affect the outcome of the CPAF test. Recendy, positive responses in the test have been attributed to previous chronic treatment with chlorpropamide, with a very low incidence in non insulindependent diabetics treated by diet alone'". None of our patients was previously treated with chlorproparnide, and the 'true' flushers were present equally in the two groups of patients on diet and in those treated with oral agents. Unlike PYEE :~, we failed to observe an increased frequency of family history of diabetes in CPAF.positive patients; the high occurrence of dominantly-inherited 'Mason type' diabetes in the population studied by Pyke might explain its higher prevalence.
We have also evaluated whether metabolic or hemostatic parameters behave differently in relation to the CPAF phenomenon. The association between high levels of triglycerides and cholesterol and a higher risk for developing macroangiopathy has been clearly demonstrated in diabetics '''~,~s Although the significance of hemostatic factors in diabetics is controversial, a number of studies has shown that ~-TG% VIII:C and fibrinogen* and VIII R:Ag 2~ are increased in complicated diabetes. Therefore, the availability of a group of patients protected against the development of severe vascular lesions seemed to give us an opportunity to investigate the role of lipid and hemostatic variables in the generation of these complications.
Our observations, however, failed to shed any light on this point, because none of the lipid and hemostatic variables was significantly different in the groups of diabetics subdivided according to their behavior in the CPAF test. These findings suggest that either these variables are not primarily involved in the development of the complications, their abnormalities in diabetes being secondary to the metabolic derangement, or that the mechanism of protection in CPAF-positive diabetics works through other routes.
Glycosylated hemoglobin as far as it does represent the metabolic control did not show differences among groups. We would also like to stress the fact that HbAI does not give any information about metabolic control during the several years of illness of our patients and could not account for differences in prevalence of lesions.
The observed differences in sex distribution with a female-increased percentage in the flushers (either aspecific or 'true' flushers) raise the question whether a sex-linked factor might explain the different distribution of lesions. In fact, we tried to consider separately the prevalence data obtained from the 'true' flusher women and to compare them with those obtained from non-flusher women without finding changes from the results obtained with the pooled data (tab. 4). It should be also considered that the aspeciflc flushers were prevailingly women (69%) and showed, nevertheless, increased prevalence of lesions. We feel therefore that the possibility that the different prevalences of lesions are to be ascribed to sex distribution can be ruled out.
Finally, we are aware that other risk factors may be claimed for vascular lesions and among them smoking. Only 18 out of our 108 patients were smokers, quite equally divided in the different groups, and only 9 of them smoked more than 10 cigarettes per day. It was therefore impossible to discriminate a specific effect of smoke.
In conclusion, we confirm the lower prevalence of vascular lesions in the CPAF-positive patients when the aspecific flushers are eliminated by a placebo test. The discordant reports concerning the percentage of positive patients may be due to the tack of objective means for judging the positiveness or to differences in the populations of" diabetics. The large scale epidemiological study and the unification of procedures recently announced by JEFFKRVS et al. ~5 must theretbre be completed before we can use the CPAF-test fbr genetic counseling and prognostic labeling in non insulin-dependent diabetics.
SUMMARY
One hundred and eight non insutindependent diabetics were tested fbr alcohol flushing after chtorpropamide administration (CPAF test). The overall prevalence of patients who flushed at the first challenge was 3?.%. However. nearly half of" them still flushed after alcohol administration, when placebo was given instead of chlorpropamide, so that the prevalence of 'true' flushers was only 17%. Even though the distribution of retinal lesions was similar in 'true' f]ushers and in non flushers, severe loss of visual acuity was confined to tile non flushers and aspecific flushers. The frequency of pathological ECG lindings and of peripheral pulse reduction or abolition was signiticantly higher in the non flushers and aspeciiic ttushers. Blood pressure, serum lipids arid hemostatic parameters were similar in the two ~'oups, and therefore do not explain the differences in prevalence of lesions. This study confirms the previous findings of a lower prevalence of large vessel lesions in flushers; however, tile prevalence of "true' CPAF phenomenon in our ore-patient population appears to be much lower than previously reported.
